Extendicare Inc
TSX:EXE

Watchlist Manager
Extendicare Inc Logo
Extendicare Inc
TSX:EXE
Watchlist
Price: 31.31 CAD 0.68% Market Closed
Market Cap: CA$3B

Wall St Price Targets

EXE Price Targets Summary
Extendicare Inc

Wall Street analysts forecast EXE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXE is 39.53 CAD with a low forecast of 22.98 CAD and a high forecast of 47.25 CAD.

Lowest Forecast
Price Target
22.98 CAD
27% Downside
Average Forecast
Price Target
39.53 CAD
26% Upside
Highest Forecast
Price Target
47.25 CAD
51% Upside
Extendicare Inc Competitors:
Price Targets
FCL
FINEOS Corporation Holdings PLC
59% Upside
RET
Retail Estates NV
8% Upside

Revenue
Forecast

-2% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-2% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 14%.

Gross Profit
Forecast

-1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Extendicare Inc

Operating Income
Forecast

2% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
2% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 20%.

Pre-Tax Income
Forecast

10% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
10% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%.

Net Income
Forecast

3% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
18%
Average Beat
3% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
18%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 3 years is 22%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EXE's stock price target?
Price Target
39.53 CAD

According to Wall Street analysts, the average 1-year price target for EXE is 39.53 CAD with a low forecast of 22.98 CAD and a high forecast of 47.25 CAD.

What is the Revenue forecast for Extendicare Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 14%.

What is the Operating Income forecast for Extendicare Inc?
Projected CAGR
20%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 20%.

What is the Net Income forecast for Extendicare Inc?
Projected CAGR
22%

Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 3 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett